New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
March 4, 2014
11:24 EDTVRMLVermillion patent for predictive markers for ovarian cancer posted by USPTO
According to a post to the USPTO site dated March 4, Vermillion applied for a patent for methods for predicting the presence, subtype and stage of ovarian cancer, as well as for assessing the therapeutic efficacy of a cancer treatment and determining whether a subject potentially is developing cancer. Associated test kits, computer and analytical systems as well as software and diagnostic models are also provided in the patent filing.
News For VRML From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
May 21, 2015
09:08 EDTVRMLVermillion approved for $7.5M grant from Cancer Prevention & Research Institute
Subscribe for More Information
May 14, 2015
09:22 EDTVRMLVermillion's OVA2 ovarain cancer triage test shows positive results
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use